St. Charles Health System

Bend, Oregon 97701

1 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Cancer, Cardiovascular Diseases, Carotid Artery Diseases, Coronary Artery Disease, Early Detection of Cancer, Early-Stage Breast Carcinoma, HER2 Positive Breast Cancer, Heart Diseases, Heart Failure, Congestive, Hormone Receptor Positive Tumor, Non-small Cell Lung Cancer

Studies at this site

• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now
• PATHFINDER 2: A Multi-Cancer Early Detection Study — Running, not enrolling
• Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease — Completed
• S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer — Stopped early
• A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer — Completed
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Trial to Assess Chelation Therapy (TACT) — Completed